APA (7th ed.) Citation

Lheureux, S., Rosen, E., Lee, E., Spigel, D., Højgaard, M., Fontana, E., . . . Yap, T. (2022). 8P Pharmacokinetic (PK) profile and food effect of RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase in patients (pts) with cancer. Annals of Oncology, 33, S4. https://doi.org/10.1016/j.annonc.2022.01.071

Chicago Style (17th ed.) Citation

Lheureux, S., et al. "8P Pharmacokinetic (PK) Profile and Food Effect of RP-3500, a Highly Potent and Specific Inhibitor of Ataxia Telangiectasia and Rad3-related (ATR) Protein Kinase in Patients (pts) with Cancer." Annals of Oncology 33 (2022): S4. https://doi.org/10.1016/j.annonc.2022.01.071.

MLA (9th ed.) Citation

Lheureux, S., et al. "8P Pharmacokinetic (PK) Profile and Food Effect of RP-3500, a Highly Potent and Specific Inhibitor of Ataxia Telangiectasia and Rad3-related (ATR) Protein Kinase in Patients (pts) with Cancer." Annals of Oncology, vol. 33, 2022, p. S4, https://doi.org/10.1016/j.annonc.2022.01.071.